Research article · 10 Apr 2024
Research articlePublished Aug 2018
Rosiglitazone Enhances the Phagocytic Ability of Thrombin-Activated Microglia through P38mapk Signaling
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objectives Hematoma formed after intracerebral hemorrhage (ICH) could results in secondary brain damage. In vitro thrombin treatment allows investigation of the pathology and mechanisms behind brain injury, and provides extracellular environment that simulates the conditions that result from ICH. Rosiglitazone treatment protects against brain damage through promoting the phagocytosis of red blood cells by microglia. The present study aimed to explore the underlying molecular mechanisms using the thrombin-induced model of ICH. Methods A total of 54 neonatal rats was used in the present study. Primary microglia were obtained from the brain tissues of neonatal SD rats, and then divided into 4 groups: normal control group (NC group), thrombin treatment group(TH group), RSG pretreatment + thrombin treatment group(RSG group), and RSG pretreatment + thrombin treatment together with p38MAPK signaling inhibitor group (SB group). Then, laser scanning confocal microscopywas used to evaluate microglial phagocytosis by observing phagocytizedred fluorescent microspheres. The mRNA and protein expression levels of CD36 were measured by RT-PCR and western blot. Results Microglial phagocytosis was increased in the RSG group compared with the other groups, and phagocytosis in the SB group was decreased compared to the RSG group. The RSG group displayed increased expression of CD36 compared to the other groups, both at protein and mRNA levels (P<0.01). The SB group expressed decreased levels of CD36 compared to the RSG group (P<0.01). Conclusions Rosiglitazone enhanced thrombin-induced phagocytosis in microglia;and the mechanism might involve increased expression of CD36 on the microglial surface through p38MAPK signaling. Keywords CD36, Intracerebral hemorrhage, Microglial cells, p38MAPK, Rosiglitazone, Thrombin
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Neuropsychiatry.
Research article · 24 Jan 2024
Insomnia Insights: A Retrospective Study of Sleep Patterns at Kuwait Centre for Mental Health over 16 years.
Commentary · 26 Dec 2023
Assessing the Impact of Eating and Sleep Disorders on Health
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalNeuropsychiatry
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Qiong Mu”
- BylineArticles whose byline prints “Likun Wang”
- BylineArticles whose byline prints “Siying Ren”
- BylineArticles whose byline prints “Hang Hang”
- BylineArticles whose byline prints “Guofeng Wu”
- BylineArticles whose byline prints “Jinbiao Luo”